Epirubicin/vinorelbine as first line therapy in metastatic breast cancer.
Baldini E, Tibaldi C, Chiavacci F, Di Lieto M, Fioretto L, Giallom-bardo A, Taviani R, Ghezzi P, Bolognini A, Conte P.
Baldini E, et al. Among authors: conte p.
Breast Cancer Res Treat. 1998 May;49(2):129-34. doi: 10.1023/a:1006059211817.
Breast Cancer Res Treat. 1998.
PMID: 9696395
Clinical Trial.